﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>13</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>11</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>A Quantitative Structure-Activity Relationship for Human Plasma Protein Binding: Prediction, Validation and Applicability Domain</ArticleTitle>
    <FirstPage>784</FirstPage>
    <LastPage>791</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2023.078</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Affaf</FirstName>
        <LastName>Khaouane</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0145-8844</Identifier>
      </Author>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Ferhat</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7923-4069</Identifier>
      </Author>
      <Author>
        <FirstName>Salah</FirstName>
        <LastName>Hanini</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9174-8545</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2023.078</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: The purpose of this study was to develop a robust and externally predictive in silico QSAR-neural network model for predicting plasma protein binding of drugs. This model aims to enhance drug discovery processes by reducing the need for chemical synthesis and extensive laboratory testing. Methods: A dataset of 277 drugs was used to develop the QSAR-neural network model. The model was constructed using a Filter method to select 55 molecular descriptors. The validation set’s external accuracy was assessed through the predictive squared correlation coefficient Q2 and the root mean squared error (RMSE). Results: The developed QSAR-neural network model demonstrated robustness and good applicability domain. The external accuracy of the validation set was high, with a predictive squared correlation coefficient Q2 of 0.966 and a root mean squared error (RMSE) of 0.063. Comparatively, this model outperformed previously published models in the literature. Conclusion: The study successfully developed an advanced QSAR-neural network model capable of predicting plasma protein binding in human plasma for a diverse set of 277 drugs. This model’s accuracy and robustness make it a valuable tool in drug discovery, potentially reducing the need for resource-intensive chemical synthesis and laboratory testing.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Quantitative structure-activity relationship</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Artificial neural network</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Prediction</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Protein-binding</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>